Dariohealth enters into strategic agreement with sanofi u.s.

New york, march 1, 2022 /prnewswire/ -- dariohealth corp. (nasdaq: drio), a leader in the global digital therapeutics (dtx) market, announced it has entered into a strategic agreement with sanofi u.s., an innovative global healthcare company. the multi-year, $30 million-dollar agreement, which is subject to certain contingencies, will help accelerate commercial adoption of dario's full suite of digital therapeutics and drive the expansion of digital health solutions on the dario platform.
DRIO Ratings Summary
DRIO Quant Ranking